BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12872450)

  • 1. A case report of synchronous double primary liver cancers combined with early gastric cancer.
    Chang JY; Kim BH; Hong SW; Kim YW; Oh JH
    Korean J Intern Med; 2003 Jun; 18(2):115-8. PubMed ID: 12872450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous occurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in both lobes of the liver.
    Topaloğlu S; Sağlam K; Çalık A; Cobanoğlu Ü; Öztürk MH
    Turk J Gastroenterol; 2014 Apr; 25(2):209-11. PubMed ID: 25003684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synchronous double primary hepatic cancer: hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Kim JO; Jun DW; Jang K
    Korean J Gastroenterol; 2013 Aug; 62(2):135-9. PubMed ID: 24133714
    [No Abstract]   [Full Text] [Related]  

  • 4. Synchronously resected double primary hepatic cancers - hepatocellular carcinoma and cholangiolocellular carcinoma.
    Matsuda M; Hara M; Suzuki T; Kono H; Fujii H
    J Hepatobiliary Pancreat Surg; 2006; 13(6):571-6. PubMed ID: 17139434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of combined liver cell and bile duct carcinoma detected 6 years after interferon therapy for chronic hepatitis C, in spite of showing complete response].
    Morizono S; Fukutomi M; Yokota M; Iguchi H; Funakoshi A; Wakasugi H; Ikeda Y; Hachitanda Y
    Nihon Shokakibyo Gakkai Zasshi; 2002 May; 99(5):505-10. PubMed ID: 12048895
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma.
    Saboo SS; Krajewski KM; Jagannathan JP; O'Regan KN; Odze R; Ramaiya N; Wolpin BM
    Cancer Imaging; 2011 Mar; 11(1):37-41. PubMed ID: 21507775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous double primary hepatic cancer consisting of hepatocellular carcinoma and cholangiolocellular carcinoma: a case report.
    Yamamoto M; Oshita A; Nishisaka T; Nakahara H; Itamoto T
    J Med Case Rep; 2018 Aug; 12(1):224. PubMed ID: 30119698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hepatocellular cholangiocarcinoma: a case report and review of literature.
    Singh S; Chakraborty S; Bonthu N; Radio S; Hussain SM; Sasson A
    Dig Dis Sci; 2013 Jul; 58(7):2114-23. PubMed ID: 23397471
    [No Abstract]   [Full Text] [Related]  

  • 10. The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma.
    Zimmerman RL; Das KM; Fogt F; Burke M; Murakata LA
    Oncol Rep; 2002; 9(6):1369-72. PubMed ID: 12375050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma.
    Uenishi T; Hirohashi K; Shuto T; Tsukamoto T; Yamamoto T; Kubo S; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2002; 49(46):1083-6. PubMed ID: 12143207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent occurrence of hepatocellular and cholangiocellular cancer nodules in the liver.
    Furuta T; Kanematsu T; Sonoda T; Sugimachi K
    Eur J Surg Oncol; 1987 Feb; 13(1):69-73. PubMed ID: 3028868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synchronous double primary cancers of a mixed adenoneuroendocrine carcinoma of the distal bile duct and a carcinoma in situ in the perihilar bile duct].
    Fujii Y; Koshita S; Kanno Y; Ogawa T; Masu K; Oikawa M; Okada T; Noda Y; Sawai T; Ito K
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(2):178-188. PubMed ID: 32037364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined hepatocellular and cholangiocellular carcinoma.
    Murakami T; Kim T; Tomoda K; Narumi Y; Sakon M; Wakasa K; Nakamura H
    Radiat Med; 1997; 15(4):243-6. PubMed ID: 9311042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined hepatocellular-cholangiocarcinoma].
    Jeen YM; Jin SY
    Korean J Hepatol; 2007 Dec; 13(4):571-5. PubMed ID: 18159156
    [No Abstract]   [Full Text] [Related]  

  • 16. Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature.
    Wu C; Bai DS; Jiang GQ; Jin SJ
    World J Surg Oncol; 2014 Nov; 12():337. PubMed ID: 25385169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
    Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
    Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Debating the presentation, morphology, origin, and prognosis of a combined hepatocellular-cholangiocarcinoma.
    Lorenzon L; Castaldo P; Bartolazzi A; Rossi Del Monte S; Camboni A; Pilozzi E; Salvi PF; Ziparo V
    Dig Dis Sci; 2013 Aug; 58(8):2423-4. PubMed ID: 23695879
    [No Abstract]   [Full Text] [Related]  

  • 19. [The value of CA19-9 in diagnosing hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Chen Y; Wang ZM; Ren ZG; Le F; Zhang BH; Xia JL; Ye SL; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):299-300. PubMed ID: 16635306
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vivo proton magnetic resonance spectroscopy of hepatocellular carcinoma and cholangiocarcinoma].
    Dong AS; Tian JM; Lu JP; Zuo CJ; Wang L; Wang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):151-4. PubMed ID: 19507591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.